<

 
Data updated 2025-07-16 00:05:01
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date96923417.8 (espacenet)  (Federated)  (European Patent Register), 19960626
Patent/reg. no. and dateDK/EP 0840791, 20020116
Publication date19980513
Priority no. and dateUS 500306, 19950710
EP pub. no. and date EP 0840791 19980513
Effective date
Applicant/ownerTHERION BIOLOGICS CORPORATION, 76 Rogers Street, Cambridge, MA 02142 , US,
THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, Office of Technology Transfer, Suite 325, 6011 Executive Boulevard
Rockville, MD 20852-3804, US
Applicant ref. no.60680
InventorSCHLOM, Jeffrey, 10301 Sorrel Avenue
Potomac, MD 20854, US,
PANICALI, Dennis L., 114 Nonset Path, Acton, MA 01720 , US
RepresentativeLarsen & Birkeholm A/S Skandinavisk Patentbureau, Banegårdspladsen 1, 1570 København V
Opponent
IPC Class A61K 38/43, A61K 45/00, A61K 45/05, C07K 16/30, C12N 15/86, C12N 9/64, C12N 15/57
TitleFrembringelse af immunreaktioner mod prostataspecifikt antigen (PSA)
Int. application no.PCT/US96/10837
Int. publication no.WO97003203
Related patent (certificate)
StatusUdløbet
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact